ZA200507112B - Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof - Google Patents
Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereofInfo
- Publication number
- ZA200507112B ZA200507112B ZA200507112A ZA200507112A ZA200507112B ZA 200507112 B ZA200507112 B ZA 200507112B ZA 200507112 A ZA200507112 A ZA 200507112A ZA 200507112 A ZA200507112 A ZA 200507112A ZA 200507112 B ZA200507112 B ZA 200507112B
- Authority
- ZA
- South Africa
- Prior art keywords
- tetrahydroquinazoline
- methods
- pyrimidine derivatives
- treatment related
- novel quinoline
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 2
- PKORYTIUMAOPED-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinazoline Chemical compound C1=CC=C2NCNCC2=C1 PKORYTIUMAOPED-UHFFFAOYSA-N 0.000 title 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45853003P | 2003-03-31 | 2003-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200507112B true ZA200507112B (en) | 2007-03-28 |
Family
ID=36819180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200507112A ZA200507112B (en) | 2003-03-31 | 2004-03-31 | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (2) | CN101475528A (en) |
| ZA (1) | ZA200507112B (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
| OA11599A (en) * | 1998-08-20 | 2004-08-23 | Agouron Pharma | Non-peptide GnRH agents, methods and intermediatesfor their preparation. |
| TW583185B (en) * | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
| CA2424964C (en) * | 2000-10-06 | 2007-12-04 | Tanabe Seiyaku Co., Ltd. | Nitrogen-containing 5-membered ring compound |
| WO2003028641A2 (en) * | 2001-10-01 | 2003-04-10 | Taisho Pharmaceutical Co., Ltd. | Mch receptor antagonists |
| US7012077B2 (en) * | 2001-12-20 | 2006-03-14 | Hoffmann-La Roche Inc. | Substituted cyclohexane derivatives |
| SE0202134D0 (en) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
-
2004
- 2004-03-31 ZA ZA200507112A patent/ZA200507112B/en unknown
- 2004-03-31 CN CNA2008101781296A patent/CN101475528A/en active Pending
- 2004-03-31 CN CNB2004800145471A patent/CN100451004C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101475528A (en) | 2009-07-08 |
| CN100451004C (en) | 2009-01-14 |
| CN1798736A (en) | 2006-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1599467T1 (en) | Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders | |
| HK1067966A1 (en) | Quinoline derivatives in combination with 5-fu or cpt-11 for use in the treatment of cancer | |
| ZA200500680B (en) | Quinoline derivatives and their use as mycrobacterial inhibitors | |
| ZA200501381B (en) | New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors | |
| AU2003284808A8 (en) | The derivatives of pyridone and the use of them | |
| AU2003216482A8 (en) | Msras as modifiers of the p53 pathway and methods of use | |
| IL177650A0 (en) | Isoquinoline derivatives and methods of use thereof | |
| HK1079518A1 (en) | Quinazolinone derivatives and their use as cb agonists | |
| AU2003216592A8 (en) | Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases | |
| ZA200410409B (en) | Use of thio-oxindole derivatives in treatment of hormonerelated conditions | |
| PL1786759T3 (en) | Novel derivatives of 3,5-seco-4-norcholestane and use thereof | |
| EP1651956A4 (en) | Melks as modifiers of the rac pathway and methods of use | |
| ZA200507112B (en) | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof | |
| SI1680405T1 (en) | Bengamide derivatives and use thereof for the treatment of cancer | |
| AU2003272400A8 (en) | Syts as modifiers of the p21 pathway and methods of use | |
| AU2003274911A8 (en) | Mrbs as modifiers of the rb pathway and methods of use | |
| AU2003300607A8 (en) | Mannuronan c5-epimerases of brown algae, methods of obtaining same and use thereof | |
| AU2003303094A8 (en) | Mat2as as modifiers of the p53 pathway and methods of use | |
| AU2003251826A8 (en) | Mp21s as modifiers of the p21 pathway and methods of use | |
| EP1534852A4 (en) | CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| HK1080110A1 (en) | Paks as modifiers of the chk pathway and methods of use | |
| AU2003294499A8 (en) | Rhebs as modifiers of the rb pathway and methods of use | |
| EP1578945A3 (en) | Cct6s as modifiers of the rb pathway and methods of use | |
| AU2003299990A8 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
| AU2003217851A8 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use |